Eric van der Putten
Direktor/Vorstandsmitglied bei Mimetas BV
Ursprung des Netzwerks ersten Grades von Eric van der Putten
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Mimetas BV
Mimetas BV BiotechnologyHealth Technology Mimetas BV develops organ-on-a-chip technology for testing of new medicines in high-throughput on miniaturized organ and disease models. It develops microfluidics-based culture plates that enable culturing and screening of a range of 3D organ and tissue models. The firm offers OrganoPlates microfluidics-based culture plates that serve as early stage screening models predicting toxic side effects and drug efficacy. The company was founded by Paul Vulto and Jos Joore in 2013 and is headquartered in Leiden, the Netherlands.
7
| Holding Company | Biotechnology | 7 |
Aglaia Management BV
Aglaia Management BV Investment ManagersFinance Aglaia Management BV is an independent venture capital investment firm headquartered in Bilthoven, the Netherlands. In 2003, Aglaia was co-founded by Mark Krul and Karl Rothweiler.
5
| Private Company | Investment Managers | 5 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Eric van der Putten
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Epoch Biosciences, Inc.
Epoch Biosciences, Inc. Medical SpecialtiesHealth Technology Epoch Biosciences, Inc. manufactures and develops molecular tools for genetic analysis. Its technology has numerous applications including the detection of inherited diseases and single nucleotide polymorphisms to identify individuals at risk for disease or adverse drug reactions and gene expression measurement. The company was founded in 1985 and is headquartered in Bothell, WA. | Medical Specialties | Director/Board Member | |
Genencor International, Inc.
Genencor International, Inc. BiotechnologyHealth Technology Genencor International, Inc. develops and manufactures enzyme product solutions for industrial, agricultural and health care markets. It finds genes and alters their proteins for use in cleaning, textile, health care, food and animal feed products using gene discovery, molecular evolution, functional genomics and immunology techniques. The company also develops solutions for the biofuels, biodefense and biosafety industries. Genencor International was founded in 1982 and is located in Rochester, NY. | Biotechnology | Chief Tech/Sci/R&D Officer | |
GALAPAGOS NV | Biotechnology | Corporate Officer/Principal | |
Abeome Corp.
Abeome Corp. BiotechnologyHealth Technology Abeome Corp. operates as a biotechnology company. It develops therapeutic and diagnostic monoclonal antibodies (mAbs). The firm’s DiSH (Direct Selection of Hybridomas) technology offers a process for selecting and cloning desired hybridomas that produce antibodies with optimal binding characteristics. The company was founded by Richard B. Meagher in 2000 and is headquartered in Athens, GA. | Biotechnology | Director/Board Member | |
Nyenrode Business Universiteit | College/University | Undergraduate Degree | |
Artax Biopharma, Inc.
Artax Biopharma, Inc. Medical SpecialtiesHealth Technology Artax Biopharma, Inc. operates as a clinical-stage biopharmaceutical company. It engages in the development of new therapies for autoimmune and inflammatory diseases. The firm develops drugs targeting the interaction between T-cell Receptors (TCR) and Nck, a cytoplasmic adapter protein which plays a role in T-cell activation. The company was founded by Dami? Carulla Tormo in 2013 and is headquartered in Cambridge, MA. | Medical Specialties | Chairman | |
GenPharm International LLC
GenPharm International LLC BiotechnologyHealth Technology GenPharm International, Inc. manufactures biopharmaceutical products. The company works towards the application of transgenic animal technology to the development of human antibody products, which are used for therapeutic uses. It was founded in 1988 and is located in San Jose, CA. | Biotechnology | Corporate Officer/Principal | |
EOS Biotechnology, Inc.
EOS Biotechnology, Inc. Pharmaceuticals: MajorHealth Technology EOS Biotechnology, Inc. develops therapeutic and diagnostic drugs. The company was founded by Herbert L. Heyneker, John Lowe, David H. Mack, David W. Martin, Richard Murray, and Stephen W. Weiss and is headquartered in Fermont, California. | Pharmaceuticals: Major | Founder | |
Mogen International Nv
Mogen International Nv Pharmaceuticals: OtherHealth Technology Part of AstraZeneca PLC, Mogen International Nv is a Dutch company that specializes in medicinal chemicals and botanical products. The company is based in Leiden, the Netherlands. Mogen International was acquired by Zeneca Group Plc on May 01, 1997 for $74.96 million. | Pharmaceuticals: Other | Corporate Officer/Principal | |
University of Georgia | College/University | Masters Business Admin | |
MAUNA KEA TECHNOLOGIES | Medical Specialties | Director/Board Member | |
University of Leiden | College/University | Doctorate Degree Doctorate Degree Graduate Degree | |
University of Utrecht | College/University | Doctorate Degree | |
NDDO Oncology BV
NDDO Oncology BV Miscellaneous Commercial ServicesCommercial Services Part of Syneos Health, Inc., NDDO Oncology BV provides product development support to pharmaceutical and biotechnology companies. The company is based in Amsterdam, Netherlands. The Dutch company was founded by Herbert Michael Pinedo. NDDO Oncology was acquired by Syneos Health NC LLC, part of Syneos Health, Inc. from December 31, 2010 on December 01, 2005. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
DSM Life Sciences Products | Corporate Officer/Principal | ||
ISA Pharmaceuticals BV
ISA Pharmaceuticals BV Pharmaceuticals: MajorHealth Technology ISA Pharmaceuticals BV operates as a clinical-stage immunotherapy company. The firm develops novel therapeutic vaccines for cancer and infectious diseases. Its product portfolio builds on its proprietary SLP-technology (Synthetic Long Peptide) for the development of therapeutic vaccines. The firm holds the exclusive rights to LUMC's patent families for amongst others, the development of therapeutic vaccines. The company was founded by Cornelis J. M. Melief in 2004 and is headquartered in Leiden, the Netherlands. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
ORCA Therapeutics BV
ORCA Therapeutics BV Pharmaceuticals: GenericHealth Technology ORCA Therapeutics BV designs and develops virotherapy drugs. The firm is a biopharmaceutical company focusing on the development of new anti-cancer treatments using Oncolytic Replication Competent Agents. It has a platform of technologies which are predominantly based on engineered oncolytic adenoviruses. The company was founded in 2005 and is headquartered in Nijmegen, the Netherlands. | Pharmaceuticals: Generic | Director/Board Member Director/Board Member | |
MERUS N.V. | Biotechnology | Director/Board Member | |
The European CanCer Organisation | Corporate Officer/Principal | ||
ProFibrix BV
ProFibrix BV BiotechnologyHealth Technology ProFibrix BV develops and markets products for the hemostasis and regenerative medicine markets. Its product in pipeline, ProFibrix, is a hemostatic agent for mild to moderate surgical bleeding. The firm operates through its offices located in Leiden and Seattle. It is a subsidiary of The Medicines Company. The company was founded in 2004 by Jaap Koopman and is headquartered in Leiden, the Netherlands. | Biotechnology | Director/Board Member | |
InteRNA Technologies BV
InteRNA Technologies BV BiotechnologyHealth Technology InteRNA Technologies BV develops RNA technologies and applications. It provides drug discovery and development services for the treatment of cancer based on the proprietary microRNA (miRNA) functions. The company develops miRNA-based therapeutics that control genes connected in signal transduction pathways and biological processes as a part of cancer initiation, progression and metastasis. InteRNA Technologies was founded by Edwin Cuppen and Eugene Berezikov in December 2006 and is headquartered in Nijmegen, the Netherlands. | Biotechnology | Director/Board Member Director of Finance/CFO Director/Board Member | |
Syngenta Mogen BV | Corporate Officer/Principal | ||
Netherlands Society of Gene Therapy | Corporate Secretary | ||
Molecular Probes Europe BV | Chief Executive Officer | ||
SomantiX BV
SomantiX BV Miscellaneous Commercial ServicesCommercial Services SomantiX BV develops imaging and therapy of cancer through targeting of tumor blood vessels. The firm offers Somantix’ screening platform which is in combination with the binder generation technologies that allows validation of new therapeutic targets and development of new cancer medicines. The company was founded in 2008 and is headquartered in Utrecht, Netherlands. | Miscellaneous Commercial Services | Chief Executive Officer | |
Cristal Delivery BV
Cristal Delivery BV Pharmaceuticals: MajorHealth Technology Cristal Delivery BV develops and manufactures nanomedicines for therapeutic drug optimization. It offers pipeline, oncology, and inflammation programs. The company was founded by Joost J. M. Holthuis and Cristianne Rijcken in April 2011 and is headquartered in Maastricht, the Netherlands. | Pharmaceuticals: Major | Director/Board Member | |
Rijksinstituut Voor Volksgezondheid En Milieu | Corporate Officer/Principal | ||
VitalneXt BV
VitalneXt BV Pharmaceuticals: GenericHealth Technology VitalneXt BV develops retails and manufactures products for healthy ageing. Its products include promanna, vital01 and other products. The firm develops products with evidence-based health benefits for the ageing population. It also develops new, proprietary, technologies, ingredients and products through its own network and through collaborations with the company's research partners. The company was founded by Rein Strijker in May 2013 and is headquartered in Amersfoort, the Netherlands. | Pharmaceuticals: Generic | Director/Board Member | |
Inthera Bioscience AG
Inthera Bioscience AG BiotechnologyHealth Technology Inthera Bioscience AG engages in the research in as well as development, production, and distribution of pharmaceutical, biological, and other products used in the fields of human and veterinary medicine. It also provides related consultancy services. The company was founded by Ulrich Kessler and Paramjit Singh Arora on September 20, 2013 and is headquartered in Zurich, Switzerland. | Biotechnology | Director/Board Member | |
Macrophage Pharma Ltd.
Macrophage Pharma Ltd. BiotechnologyHealth Technology Macrophage Pharma Ltd. engages in research and experimental development on biotechnology. The company is headquartered in Berkhamsted, the United Kingdom. | Biotechnology | Director/Board Member | |
Biosanapharma BV
Biosanapharma BV Pharmaceuticals: MajorHealth Technology Biosanapharma BV is a Dutch pharmaceutical company that manufactures and distributes pharmaceutical products. The private company is based in Leiden, Netherlands. The CEO of the company is Ard Tijsterman. | Pharmaceuticals: Major | Director/Board Member | |
Sapreme Technologies BV
Sapreme Technologies BV BiotechnologyHealth Technology Sapreme Technologies BV operates as a biotech company that develops a platform technology to enable cytosolic delivery of macromolecule therapeutics. The company was founded by Ruben Postel in 2016 and is headquartered in Utrecht, the Netherlands. | Biotechnology | Director/Board Member | |
Fibrocor Therapeutics LP
Fibrocor Therapeutics LP Miscellaneous Commercial ServicesCommercial Services Fibrocor Therapeutics LP is a privately held Canadian drug discovery company that is pioneering the use of tissue-specific therapeutics in the field of precision medicine, particularly in fibrosis. The company is based in Toronto, Canada. The company aims to improve the lives of patients by delivering transformative treatments that tackle the root causes of fibrosis, leading to better outcomes and enhanced quality of life. Fibrocor leverages its extensive expertise and one of the largest patient-derived clinically annotated biorepositories of fibrotic tissue to refine and validate therapeutic candidates, ensuring they meet the highest standards of efficacy and safety. | Miscellaneous Commercial Services | Director/Board Member | |
Pepscope BV
Pepscope BV Miscellaneous Commercial ServicesCommercial Services Pepscope BV is a company based in Utrecht, Netherlands that develops and provides advanced customer-focused protein analysis services and products. The Dutch company aims to make kinase inhibitors better therapeutics by providing unique insights into their functioning through quantitative profiling of the kinome in cells and tissues. Pepscope offers a unique, targeted mass-spectrometry-based, multiplexed, endogenous kinase activity profiling technology for clinical samples. Recently, Pepscope announced a 4.3-million-euro funding round to further develop and commercialize their lead product QuantaKinome™, which provides direct insights into the activities of hundreds of protein kinases simultaneously inside the cells of diseased tissues. Pepscope offers QuantaKinome™ to the pharmaceutical industry and academic researchers to improve the discovery and development of drugs. The company was founded by Jos Joore, Hans Brouwer, and Anna Ressa, with Anna Ressa serving as the CEO since incorporation. | Miscellaneous Commercial Services | Founder |
Statistik
International
Niederlande | 25 |
Vereinigte Staaten | 12 |
Belgien | 3 |
Frankreich | 2 |
Schweiz | 2 |
Sektoral
Health Technology | 25 |
Commercial Services | 6 |
Consumer Services | 5 |
Electronic Technology | 2 |
Health Services | 2 |
Operativ
Director/Board Member | 29 |
Corporate Officer/Principal | 13 |
Founder | 7 |
Chief Tech/Sci/R&D Officer | 5 |
Chief Executive Officer | 5 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Eric van der Putten
- Unternehmensverbindungen